GCTK

Glucotrack

2.47

-0.94-27.57%

Opening14:15 01/29 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE3.380/3.410

TODAY RANGE2.330-3.440

VOL14.04M

MARKET CAP2.25M

52 WEEK RANGE2.330-133.80

AVG VOL (3M)84.29K

% TURNOVER1,541.20%

TURNOVER--

P/E (TTM)-0.0020

% RANGE32.55%

EPS(TTM)-1,225.5942

P/E(FORWARD)--

P/B0.8075

BVPS3.059

DIVIDEND--

P/S384.62

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP2.12M

SHARES OUTSTANDING910.69K

NEXT EARNINGS--

FREE FLOAT858.95K

LOT SIZE1

EX-DATE06/16/2025

News

Press Releases

Financial Reports

Profile

TipRanks·4h ago
GlucoTrack Strengthens IP for Implantable Glucose Monitoring Platform
Reuters·6h ago
GlucoTrack Secures USPTO Patents for Fully Implantable Continuous Blood Glucose Monitoring System
TipRanks·01/13 21:10
GlucoTrack files to sell 3.22M shares of common stock for holders
TipRanks·12/31/2025 21:35
GlucoTrack strengthens capital position with new private placement
TipRanks·12/30/2025 13:05
GlucoTrack prices 1.03M shares at $3.87 in private placement
Reuters·12/30/2025 13:00
GLUCOTRACK, INC. ANNOUNCES PRICING OF $4.0 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES WITH A SINGLE INSTITUTIONAL INVESTOR
TipRanks·12/29/2025 13:27
GlucoTrack Issues Investor Presentation Under Regulation FD
TipRanks·11/19/2025 04:05
Glucotrack Reports Q3 2025 Results and Strategic Progress
Reuters·11/13/2025 21:13
Glucotrack reports Q3 net loss of $15.8 million on $7.9 million cash balance
Reuters·11/07/2025 22:16
GlucoTrack Inc. Held Shareholder Meeting
Reuters·11/06/2025 12:46
GlucoTrack Adjourns Shareholder Meeting Due to Lack of Quorum
TipRanks·11/03/2025 22:18
GlucoTrack Announces Special Shareholders Meeting for Equity Deal
TipRanks·10/29/2025 20:59
GlucoTrack Appoints Dr. Usman Latif to Advisory Team
Reuters·10/29/2025 20:05
GlucoTrack Names Neuromodulation Expert Usman Latif to Clinical Advisory Team
TipRanks·10/29/2025 13:41
GlucoTrack Inc trading resumes

Same Industry

Name/Symbol

Change%

Price

Glucotrack

GCTK

-27.57%

2.47

Regeneron Pharmaceuticals

REGN

-0.42%

747.96

GridAI Tech

GRDX

-0.50%

2.99

BIONTECH

BNTX

+0.74%

117.02

United Therapeutics Corp.

UTHR

+0.05%

467.54

Vertex Pharmaceuticals Inc

VRTX

-0.63%

474.89

Siga Technologie

SIGA

+0.45%

6.70

Moderna

MRNA

+2.67%

46.51

Charles Riv Labs Intl Inc

CRL

-1.81%

212.96

Medpace Holdings

MEDP

-1.45%

589.26

Talphera Inc

TLPH

0.00%

0.9899

ICON PLC

ICLR

-2.40%

181.84

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

-1.69%

235.72

MOLECULAR PARTNERS AG

MOLN

-0.12%

4.15

Arcturus Therape

ARCT

+2.44%

7.55

Gilead Sciences Inc

GILD

-0.26%

139.36

PRA Health

PRAH

0.00%

165.21

Incyte Corp

INCY

+0.15%

101.33

Aptevo Therapeutics Inc

APVO

-8.23%

7.19

Biospecifics

BSTC

0.00%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.